Solvonis Therapeutics plc (LON:SVNS)
London · Delayed Price · Currency is GBP · Price in GBX 0.2960
+0.0260 (9.63%)
At close: Jan 23, 2026
Solvonis Therapeutics Market Cap
Solvonis Therapeutics has a market cap or net worth of 20.15 million as of January 23, 2026. Its market cap has increased by 401.43% in one year.
Market Cap
20.15M
Enterprise Value
18.50M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.30
Market Cap Chart
Since January 6, 2022, Solvonis Therapeutics's market cap has decreased from 23.03M to 20.15M, a decrease of -12.52%. That is a compound annual growth rate of -3.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 18.38M | -12.90% |
| Dec 31, 2025 | 21.10M | 348.30% |
| Dec 31, 2024 | 4.71M | 686.33% |
| Dec 29, 2023 | 598.56K | -95.86% |
| Dec 30, 2022 | 14.47M | -37.18% |
| Jan 6, 2022 | 23.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Smiths Group | 8.11B |
| The Weir Group | 7.93B |
| Melrose Industries | 7.86B |
| IMI plc | 6.41B |
| Spirax Group | 5.17B |
| Rotork | 2.81B |
| Goodwin | 1.81B |
| Bodycote | 1.30B |